Your email has been successfully added to our mailing list.

×
-0.0261282660332542 -0.0261282660332542 0.0142992874109264 0.0142992874109264 0.0497149643705463 0.0497149643705463 0.0497149643705463 0.0485273159144893
Stock impact report

Edited Transcript of GLMD earnings conference call or presentation 6-Nov-19 1:30pm GMT [Yahoo! Finance News]

Galmed Pharmaceuticals Ltd. - Ordinary Shares (GLMD) 
Last galmed pharmaceuticals ltd. - ordinary shares earnings: 3/12 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: galmedpharma.investorroom.com
Edited Transcript of GLMD earnings conference call or presentation 6-Nov-19 1:30pm GMT All subjects enrolled are overweight or obese and have pre-diabetes or type II diabetes. This targeted homogeneous population was selected taking into consideration that type II diabetes is an important risk factor for NASH and is therefore considered a population with an urgent unmet need. The study consists of 2 parts. The first part, histology based, includes 1,200 subjects treated for 52 weeks and is powered to meet both key endpoints: NASH resolution and no worsening of liver fibrosis; and fibrosis improvement without NASH worsening. Meeting either of these endpoints is expected to suffice for the study to succeed at the end of part 1. These data will serve as the basis for the submission of a marketing authorization application under regulatory provisions of accelerated/conditional approval. We look forward to rapidly completing enrollment by Q2 of 2021 with the aim of reporting top line resul Show less Read more
Impact Snapshot
Event Time:
GLMD
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for
GLMD alerts

from News Quantified
Opt-in for
GLMD alerts

from News Quantified